STOCK TITAN

Byrna Technologies (NASDAQ: BYRN) shares new investor presentation

(Moderate)
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Byrna Technologies Inc. (BYRN) reports that it has furnished, under a current report on Form 8-K, an updated investor presentation dated August 25, 2026 as Exhibit 99.1 under Regulation FD Item 7.01. The company states this information is "furnished" and not "filed" and will not be incorporated into other securities law filings unless specifically referenced.

Positive

  • None.

Negative

  • None.
Item 7.01 Regulation FD Disclosure Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Investor presentation date August 25, 2026 Date of the Investor Presentation attached as Exhibit 99.1
Common Stock par value $0.001 per share Par value of Byrna Technologies Inc. common stock listed on Nasdaq Capital Market
Company telephone number (978) 868-5011 Telephone number for Byrna Technologies Inc.’s principal executive offices
Regulation FD regulatory
"furnishes the updated investor presentation attached as Exhibit 99.1 to this"
Regulation FD is a rule that prevents company insiders, like executives, from sharing important information with some people before others get it. It matters because it helps ensure all investors have equal access to key news, making the stock market fairer and reducing chances of insider trading.
Emerging growth company regulatory
"405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
Inline XBRL technical
"Cover Page Interactive Data File (embedded within the Inline XBRL document)"
Inline XBRL is a file format for financial filings that embeds machine-readable data tags directly inside the human-readable report, so the same document can be read by people and parsed by software. For investors it makes extracting, comparing and verifying financial numbers faster and more reliable—like a grocery list where each item also has a barcode—reducing manual errors and speeding up analysis.

FAQ

What did Byrna Technologies Inc. (BYRN) announce in this Form 8-K?

Byrna Technologies Inc. furnished an updated investor presentation dated August 25, 2026 as Exhibit 99.1 under Item 7.01 (Regulation FD Disclosure). The company may use this presentation in meetings with investors from time to time.

Is the BYRN investor presentation in Exhibit 99.1 considered "filed" with the SEC?

No. Byrna states that the information in Item 7.01, including Exhibit 99.1, is "furnished" and not "filed" for purposes of Section 18 of the Exchange Act and is not subject to that section’s liability, unless specifically incorporated by reference in another filing.

What is Exhibit 99.1 in Byrna Technologies Inc.’s (BYRN) Form 8-K?

Exhibit 99.1 is an Investor Presentation dated August 25, 2026. Byrna indicates it may use this presentation in discussions with investors from time to time.

Under which item of Form 8-K did BYRN furnish the investor presentation?

Byrna furnished the investor presentation under Item 7.01, Regulation FD Disclosure. The company characterizes the material as furnished rather than filed.

Who signed the August 25, 2026 Form 8-K for Byrna Technologies Inc. (BYRN)?

The Form 8-K was signed on behalf of Byrna Technologies Inc. by Laurilee Kearnes, who is identified as the company’s Chief Financial Officer.

On which market is Byrna Technologies Inc. (BYRN) common stock listed?

Byrna Technologies Inc.’s common stock, par value $0.001 per share, is listed on the Nasdaq Capital Market under the trading symbol BYRN.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
false 0001354866 0001354866 2026-08-25 2026-08-25
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): August 25, 2026
 
BYRNA TECHNOLOGIES INC.
(Exact name of registrant as specified in its charter)
 
Delaware
(State or other jurisdiction of incorporation)
 
333-132456
 
71-1050654
(Commission File Number)
 
(IRS Employer Identification No.)
 
100 Burtt Road, Suite 115
Andover, MA 01810
(Address and Zip Code of principal executive offices)
 
(978) 868-5011
(Registrant’s telephone number, including area code)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
 Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
 Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
 Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
 Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
Trading Symbol(s)
Name of exchange on which registered
Common Stock, $0.001 par value
BYRN
Nasdaq Capital Market
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
Emerging growth company 
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 

 
Item 7.01
Regulation FD Disclosure.
 
Byrna Technologies Inc. (the “Company”) hereby furnishes the updated investor presentation attached as Exhibit 99.1 to this Current Report on Form 8-K, which the Company may use in presentations to investors from time to time.
 
The information in this Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liability of such section, nor shall it be deemed incorporated by reference in any filing of the Company under the Securities Act of 1933 or the Securities Exchange Act of 1934, regardless of any general incorporation language in such filing, unless expressly incorporated by specific reference in such filing.
 
Item 9.01.
Financial Statements and Exhibits.
 
Exhibit
No.
 
Description
 
 
 
(d)
 
Exhibits.
99.1
 
Investor Presentation, dated August 25, 2026.
104
 
Cover Page Interactive Data File (embedded within the Inline XBRL document)
 

 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
BYRNA TECHNOLOGIES INC.
 
 
Date: August 25, 2026
By:
/s/ Laurilee Kearnes
 
 
Name: Laurilee Kearnes
Title: Chief Financial Officer
 

Exhibit 99.1

 

slide01.jpg

 


slide02.jpg

 


slide03.jpg

 


slide04.jpg

 


slide05.jpg

 


slide06.jpg

 


slide07.jpg

 


slide08.jpg

 


slide09.jpg

 


slide10.jpg

 


slide11.jpg

 


slide12.jpg

 


slide13.jpg

 


slide14.jpg

 


slide15.jpg

 


slide16.jpg

 


slide17.jpg

 


slide18.jpg

 


slide19.jpg

 


slide20.jpg

 


slide21.jpg

 


slide22.jpg

 

Filing Exhibits & Attachments

5 documents